Pitcairn’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,170
| Closed | -$215K | – | 645 |
|
|
2021
Q2 | $215K | Buy |
+1,170
| New | +$201K | 0.01% | 580 |
|
|
2019
Q3 | – | Sell |
-1,874
| Closed | -$246K | – | 560 |
|
|
2019
Q2 | $246K | Sell |
1,874
-634
| -25% | -$81.7K | 0.02% | 469 |
|
|
2019
Q1 | $339K | Sell |
2,508
-656
| -21% | -$81.6K | 0.04% | 318 |
|
|
2018
Q4 | $309K | Sell |
3,164
-584
| -16% | -$69K | 0.03% | 291 |
|
|
2018
Q3 | $521K | Sell |
3,748
-446
| -11% | -$55.9K | 0.05% | 243 |
|
|
2018
Q2 | $521K | Sell |
4,194
-281
| -6% | -$32.8K | 0.06% | 246 |
|
|
2018
Q1 | $499K | Sell |
4,475
-777
| -15% | -$92.9K | 0.05% | 244 |
|
|
2017
Q4 | $628K | Sell |
5,252
-1,432
| -21% | -$174K | 0.06% | 225 |
|
|
2017
Q3 | $938K | Sell |
6,684
-518
| -7% | -$70.4K | 0.11% | 137 |
|
|
2017
Q2 | $876K | Sell |
7,202
-13,229
| -65% | -$1.54M | 0.11% | 135 |
|
|
2017
Q1 | $2.48M | Sell |
20,431
-8,216
| -29% | -$1.06M | 0.3% | 45 |
|
|
2016
Q4 | $3.5M | Buy |
28,647
+1,751
| +7% | +$214K | 0.43% | 28 |
|
|
2016
Q3 | $3.3M | Buy |
26,896
+6,242
| +30% | +$803K | 0.41% | 28 |
|
|
2016
Q2 | $2.41M | Buy |
20,654
+5,068
| +33% | +$719K | 0.31% | 42 |
|
|
2016
Q1 | $2.17M | Sell |
15,586
-796
| -5% | -$117K | 0.27% | 52 |
|
|
2015
Q4 | $3.13M | Buy |
16,382
+2,835
| +21% | +$495K | 0.35% | 39 |
|
|
2015
Q3 | $2.12M | Buy |
13,547
+4,483
| +49% | +$818K | 0.28% | 55 |
|
|
2015
Q2 | $1.64M | Buy |
9,064
+3,686
| +69% | +$636K | 0.19% | 99 |
|
|
2015
Q1 | $932K | Sell |
5,378
-731
| -12% | -$132K | 0.1% | 164 |
|
|
2014
Q4 | $1.13M | Sell |
6,109
-465
| -7% | -$86.2K | 0.12% | 139 |
|
|
2014
Q3 | $1.09M | Sell |
6,574
-65
| -1% | -$10.7K | 0.12% | 143 |
|
|
2014
Q2 | $1.04M | Sell |
6,639
-471
| -7% | -$74.4K | 0.12% | 148 |
|
|
2014
Q1 | $1.08M | Sell |
7,110
-6,961
| -49% | -$1.11M | 0.12% | 141 |
|
|
2013
Q4 | $1.87M | Buy |
14,071
+539
| +4% | +$64.7K | 0.21% | 85 |
|
|
2013
Q3 | $1.57M | Sell |
13,532
-2,154
| -14% | -$236K | 0.19% | 100 |
|
|
2013
Q2 | $1.45M | Buy |
+15,686
| New | +$1.51M | 0.19% | 108 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM